<DOC>
	<DOC>NCT02046512</DOC>
	<brief_summary>The purpose of this study is to evaluate the effectiveness of bacteria called Lactobacillus GG, a Probiotic, in preventing the growth of resistant bacteria in the digestive tract in patients on broad spectrum antimicrobials.</brief_summary>
	<brief_title>Probiotics to Promote Intestinal Health</brief_title>
	<detailed_description />
	<mesh_term>Communicable Diseases</mesh_term>
	<mesh_term>Infection</mesh_term>
	<criteria>Adults â‰¥ 18 years old Admission to the nonICU medical and surgical wards On broad spectrum antimicrobials with an anticipated length of stay of &gt;48 hours Pregnancy Non English speaking Expected to die within 7 days Unable or unwilling to consent HIV infection with a CD4 count &lt;200 Neutropenia with an absolute neutrophil count less than 500 cells/ml (or expected to drop to less than 500) Clinically significant diarrhea or history of C. difficile infection in the last 3 months History of VRE colonization and/or infection in the last year Transplant recipients</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>Probiotics</keyword>
</DOC>